Bioprojet-Biotech, 4 rue du Chesnay Beauregard, BP 96205, 35762 Saint Grégoire, France.
Chemveda Life Sciences India Pvt. Ltd., #B-11/1, IDA Uppal, Hyderabad 500039, Telangana, India; Jawaharlal Nehru Technological University Hyderabad, Kukatpally, Hyderabad 500 085, Telangana, India.
Bioorg Med Chem. 2022 Sep 1;69:116851. doi: 10.1016/j.bmc.2022.116851. Epub 2022 Jun 20.
During our work on exploration of molecules with some piperidine-triazole scaffolds, we realized that our compounds display chemical similarity with some σ, as well as dopaminergic receptor ligands. Here we show that this series of molecules has indeed strong affinity both for σ1 and dopamine D4 receptors. Moreover, they appear selective towards σ2, dopamine paralogues D1, D2, D3 and D5 receptors and hERG channel. Extensive molecular dynamics with our lead compound AVRM-13 were carried out on σ1, supporting agonist activity of the ligand. Unexpectedly, several observations suggested the existence of a cation binding domain, a probable regulatory site for calcium.
在探索具有哌啶-三唑骨架的分子的过程中,我们意识到我们的化合物在化学上与一些 σ 以及多巴胺能受体配体相似。在这里,我们证明了这一系列分子确实对 σ1 和多巴胺 D4 受体具有很强的亲和力。此外,它们对 σ2、多巴胺同工型 D1、D2、D3 和 D5 受体以及 hERG 通道表现出选择性。我们对先导化合物 AVRM-13 进行了广泛的分子动力学研究,支持了配体的激动剂活性。出乎意料的是,有几个观察结果表明存在一个阳离子结合域,这可能是钙的调节位点。